EUVIMEDEUVIMED entdecken
Open Access

Coordinated changes in oral propionate, oral microbiota, and peripheral blood inflammatory processes during peanut oral immunotherapy

Lingdi Zhang, Yoojin Chun, Samantha Valeiron, Galina Grishina, Tracy Lo, Julie Wang, Scott Sicherer, Supinda Bunyavanich

Journal of Allergy and Clinical Immunology · 2026-09

DOI: 10.1016/j.jaci.2026.08.015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2026-09. Verfasst von Lingdi Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Peanut allergy is an increasingly prevalent condition without curative treatment. Oral immunotherapy (OIT) can induce desensitization, but its mechanisms are not fully understood. Administration of oral short-chain fatty acids (SCFAs) in murine models induces favorable immunomodulation that overlaps with processes observed in OIT. OBJECTIVE: We hypothesized that oral short-chain fatty acid levels change during OIT and are associated with systemic downregulation of type 2 processes. METHODS: Within a clinical trial of children aged 4-14 years with high-threshold peanut allergy randomized to OIT or avoidance, we profiled oral short-chain fatty acid levels, the oral microbiome, and peripheral blood transcriptome over the course of OIT or avoidance. Statistical and network analyses were carried out to test our hypotheses. TRIAL REGISTRATION: ClinicalTrials.gov NCT03907397. RESULTS: Among the 56 children in the clinical trial with complete multiomic profiles over the trial duration, 29 were randomized to OIT and 27 to avoidance. All participants in the OIT group obtained desensitization compared to 18.5% in the avoidance group. Oral levels of short-chain fatty acid propionate increased with OIT but not avoidance (false discovery rate [FDR] = 0.042) and remained elevated with sustained unresponsiveness. Oral propionate levels positively correlated with the relative abundances of several oral microbes, including known propionate producers Prevotella spp (r = 0.47, FDR 3.75 × 10-3) and Veillonella (r = 0.39, FDR 1.45 × 10-2). Oral propionate levels negatively correlated with peripheral blood transcript expression of OIT-associated Fcγ receptors (FDR FcγR 0.05), IL-4 and IL-13 signaling (FDR FcγR 0.05), and neutrophil degranulation pathways (FDR FcγR 0.05). CONCLUSIONS: This study raises the intriguing possibility that oral propionate may serve as an important immunoregulatory bridge between local and systemic processes in peanut OIT.

Schlagwörter

Stichwörter der Autor:innen

Fcγ receptorsIL-13IL-4Peanut allergyfood allergymicrobiomeoral immunotherapypropionateshort-chain fatty acidstranscriptome

Autor:innen und Institutionen

  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Serena and John Liew Division of Allergy and Immunology, Jaffe Food Allergy Institute, Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY; Serena and John Liew Division of Allergy and Immunology, Jaffe Food Allergy Institute, Department of Pediatrics, Icahn…

Förderung

  • NIAID NIH HHS
  • National Institutes of Health

Zitieren

APA

Zhang, L., Chun, Y., Valeiron, S., Grishina, G., Lo, T., Wang, J., Sicherer, S., & Bunyavanich, S. (2026). Coordinated changes in oral propionate, oral microbiota, and peripheral blood inflammatory processes during peanut oral immunotherapy. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2026.08.015

Vancouver

Zhang L, Chun Y, Valeiron S, Grishina G, Lo T, Wang J, et al. Coordinated changes in oral propionate, oral microbiota, and peripheral blood inflammatory processes during peanut oral immunotherapy. Journal of Allergy and Clinical Immunology. 2026. doi:10.1016/j.jaci.2026.08.015

BibTeX
@article{Zhang2026,
  author = {Zhang, Lingdi and Chun, Yoojin and Valeiron, Samantha and Grishina, Galina and Lo, Tracy and Wang, Julie and Sicherer, Scott and Bunyavanich, Supinda},
  title = {Coordinated changes in oral propionate, oral microbiota, and peripheral blood inflammatory processes during peanut oral immunotherapy},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2026},
  doi = {10.1016/j.jaci.2026.08.015}
}
Kostenlos starten →